AI Verdict
MEDP has stronger fundamentals based on our AI analysis.
MEDP vs MED Fundamental Comparison
| Metric | MEDP | MED |
|---|---|---|
| Revenue | $2.5B | $385.8M |
| Net Income | $451.1M | $-18.7M |
| Net Margin | 17.8% | -4.8% |
| ROE | 98.3% | -9.4% |
| ROA | 22.8% | -7.5% |
| Current Ratio | 0.74x | 4.69x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $15.28 | $-1.70 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MEDP vs MED: Frequently Asked Questions
Is MEDP or MED a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MEDP has stronger fundamentals. MEDP is rated STRONG BUY (87% confidence) while MED is rated SELL (85% confidence). This is not investment advice.
How does MEDP compare to MED fundamentally?
Medpace Holdings, Inc. has ROE of 98.3% vs MEDIFAST INC's -9.4%. Net margins are 17.8% vs -4.8% respectively.
Which stock pays higher dividends, MEDP or MED?
MEDP has a dividend yield of N/A or no dividend while MED has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MEDP or MED for long term?
For long-term investing, consider that MEDP has STRONG BUY rating with 87% confidence, while MED has SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MEDP vs MED?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MEDP vs MED, the AI consensus favors MEDP based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.